JUMPCAN(SH:600566) Shang Hai Zheng Quan Bao·2025-12-01 19:01Core Viewpoint - Hubei Jichuan Pharmaceutical Co., Ltd. has announced a share repurchase plan to enhance employee stock ownership and equity incentives, with a total repurchase amount between RMB 25 million and RMB 50 million, and a maximum repurchase price of RMB 38 per share [4]. Group 1: Share Repurchase Plan - The company held its 19th meeting of the 10th Board of Directors on November 24, 2025, where it approved the share repurchase plan [4]. - The repurchase will utilize the company's own funds through centralized bidding and is intended for employee stock ownership plans or equity incentives [4]. - The implementation period for the share repurchase is set to not exceed 12 months from the date of the board's approval [4]. Group 2: Shareholder Information - The announcement includes details about the top ten shareholders and their respective shareholding percentages as of November 24, 2025 [1][2]. - The total share capital of the company on that date was 921,387,060 shares, with the top ten shareholders holding a significant portion of the shares [1]. - The total number of unrestricted circulating shares was 918,105,360, which is relevant for understanding the liquidity and ownership structure [2]. Group 3: Progress of Share Repurchase - As of November 30, 2025, the company has not yet implemented any share repurchase [6]. - The company is required to announce the progress of the share repurchase within three trading days before the end of each month during the repurchase period [5]. - The company will adhere to relevant regulations and make repurchase decisions based on market conditions [7].